Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia

• Main Authors: Xiaoyan Mao (Author), Runxiu Yin (Author), Li Liu (Author), Yan Zhou (Author), Chunhui Yang (Author), Chunlian Fang (Author), Hongchao Jiang (Author), Qulian Guo (Author), Xin Tian (Author)
• Format: Book
• Published: Elsevier, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Corebinding factor acute myeloid leukemia (CBF-AML) is the most common cytogenetic subtype of pediatric AML. CBF-AML is associated with a relatively favorable outcome, although the relapse rate of approximately 40% indicates a high degree of clinical heterogeneity. The clinical impact of...